<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="65394">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01830738</url>
  </required_header>
  <id_info>
    <org_study_id>LOCAL/2012/VL-03</org_study_id>
    <secondary_id>2012-A01054-36</secondary_id>
    <nct_id>NCT01830738</nct_id>
  </id_info>
  <brief_title>Laparoscopic Hysterectomy Via a Single Port, Peri-umbilical Technique Versus a Conventional Laparoscopic Technique</brief_title>
  <acronym>HOT</acronym>
  <official_title>Laparoscopic Hysterectomy Via a Single Port, Peri-umbilical Technique Versus a Conventional Laparoscopic Technique : a Prospective, Randomized, Multicenter Study Evaluating the Length of Hospital Stay</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Nīmes</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Nīmes</source>
  <oversight_info>
    <authority>France: Committee for the Protection of Personnes</authority>
    <authority>France: Agence Nationale de Sécurité du Médicament et des produits de santé</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main objective of the study is the comparison of the effective duration of
      hospitalization following laparoscopic hysterectomy via a single-port peri-umbilical
      technique versus an conventional multi-port technique.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The secondary objectives are to compare the following between the two arms of the study:

        1. the difference between the real discharge date and the theoretical discharge date

        2. measures related to intraoperative bleeding

        3. operating time

        4. postoperative pain

        5. quality of life

        6. abdominal wall complication rates

        7. rates of further surgery and rehospitalization

        8. use of material resources in the operating room

        9. average costs of hospital stay

       10. Costs of rehospitalization at 1 year

       11. Indirect costs
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2014</start_date>
  <completion_date type="Anticipated">August 2016</completion_date>
  <primary_completion_date type="Anticipated">September 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Length of hospital stay in hours</measure>
    <time_frame>Maximum 1 month (usually 3 to 5 days)</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Difference in hours between real discharge time and theoretical discharge time</measure>
    <time_frame>4 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>Criteria for theoretical hospital discharge:
Visual analog scale for pain &lt; 2 under stage 1 antalgics
No nausea, no vomiting
Resumption of transit, liquid and solid food
Capable of getting up, moving and going to the bathroom alone
Apyrexia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bleeding/fluid loss: Difference between lavage fluids and aspiration fluids</measure>
    <time_frame>Day 0 (during surgery)</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in hemoglobin measure</measure>
    <time_frame>Day 3 versus baseline</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in hematocrit measure</measure>
    <time_frame>Day 3 versus baseline</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Surgical time, from first incision to closing</measure>
    <time_frame>Day 0 (during surgery)</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual analog scale for pain</measure>
    <time_frame>2 hours after end of surgery (Day 0)</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual analog scale for pain</measure>
    <time_frame>3 times per day during hospitalisation (expected maximum of 3 to 5 days)</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Questionnaire SF 36</measure>
    <time_frame>baseline</time_frame>
    <safety_issue>No</safety_issue>
    <description>Quality of Life</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Questionnaire SF 36</measure>
    <time_frame>4 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>Quality of Life</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complication rate</measure>
    <time_frame>Day 1</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Includes: hematomas around trocar sites; localized care for trocar infection or hematoma; surgery for trocar site herniation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complication rate</measure>
    <time_frame>4 weeks</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Includes: hematomas around trocar sites; localized care for trocar infection or hematoma; surgery for trocar site herniation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complication rate</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Includes: hematomas around trocar sites; localized care for trocar infection or hematoma; surgery for trocar site herniation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Re-intervention/hospitalisation rate</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Surgical conversion rate</measure>
    <time_frame>Day 0 (during surgery)</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Trocar site infection rate</measure>
    <time_frame>4 weeks</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Presence/absence of complications according to Clavien scale</measure>
    <time_frame>Day 1</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Presence/absence of complications according to Clavien scale</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inventory of reusable material in the operating room and related costs.</measure>
    <time_frame>Day 0 (after surgery)</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Estimatin of indirect costs</measure>
    <time_frame>4 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Estimation of direct costs</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Questionnaire SF 36</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Quality of Life</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">140</enrollment>
  <condition>Hysterectomy</condition>
  <arm_group>
    <arm_group_label>Peri-umbilical single-port</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients in this arm have a hysterectomy via a single-port peri-umbilical laparoscopic surgical technique.
Intervention:  Single-port, peri-umbilical hysterectomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Multi-port</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients in this arm have a hysterectomy via a conventional multi-port  laparoscopic surgical technique.
Intervention: Multi-port hysterectomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Single-port, peri-umbilical hysterectomy</intervention_name>
    <description>Patients in this arm have a hysterectomy via a single-port peri-umbilical laparoscopic surgical technique.</description>
    <arm_group_label>Peri-umbilical single-port</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Multi-port hysterectomy</intervention_name>
    <description>Patients in this arm have a hysterectomy via a conventional multi-port laparoscopic surgical technique.</description>
    <arm_group_label>Multi-port</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The patient must have given her informed and signed consent

          -  The patient must be insured or beneficiary of a health insurance plan

          -  The patient is available for 12 months of follow-up

          -  The patient is declared fit by the anesthetist for an intervention by laparoscopy

        Exclusion Criteria:

          -  The patient is not available for 12 months of follow-up

          -  The patient is participating in another study or is in an exclusion period determined
             by a previous study

          -  The patient is under judicial protection, under tutorship or curatorship

          -  The patient is not insured or beneficiary of a health insurance plan

          -  The patient refuses to sign the consent

          -  It is impossible to correctly inform the patient

          -  The patient cannot read French

          -  Patient with a history of pelvic radiotherapy

          -  Patient with a history of pelvic surgery or serious risk of major adhesions

          -  The patient is pregnant

          -  Contraindications for anesthesia for either surgical technique

          -  Promontofixation or lymphadenectomy

          -  No associated procedure other than morcellation or vaginal suture for extracting the
             hysterectomy specimen, unilateral or bilateral oophorectomy

          -  The patient has a known or suspected allergy to polyurethane

          -  Extended hysterectomy for neoplastic disease
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vincent Letouzey, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Hospitalier Universitaire de Nîmes</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Vincent Letouzey, MD</last_name>
    <phone>+33.(0)4.66.68.32.16</phone>
    <email>vincent.letouzey@chu-nimes.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Carey Suehs, PhD</last_name>
    <phone>+33.(0)4.66.68.67.88</phone>
    <email>carey.suehs@chu-nimes.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU de Nîmes - Hôpital Universitaire Carémeau</name>
      <address>
        <city>Nîmes Cedex 9</city>
        <zip>30029</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Vincent Letouzey, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Olivier Pouget, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Florent Masia, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Renaud de Tayrac, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pierre Marès, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mélanie Cayrac, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Céline Chauleur, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>May 9, 2014</lastchanged_date>
  <firstreceived_date>April 10, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>laparoscopy</keyword>
  <keyword>hysterectomy</keyword>
  <keyword>single-port trocar</keyword>
  <keyword>surgical technique</keyword>
  <keyword>trocar</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
